Shelter Pharma

Shelter Pharma

46.00
0.00
(0.00%)
Market Cap
53.20 Cr
EPS
6.26
PE Ratio
7.35
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
69.70
52 Week Low
35.70
PB Ratio
1.27
Debt to Equity
0.05
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,606.40
#1 3,85,429.17
33.33
#1 54,729.00
9.71
#1 10,980
-19.84
43.49
6,034.00
1,60,183.74
69.42
9,712.00
18.67
2,191
26.74
38.09
1,560.00
1,26,002.42
23.42
28,409.50
7.12
5,291
9.88
49.52
3,588.40
1,21,447.76
60.22
11,539.40
6.99
1,911
19.91
57.02
1,295.10
1,08,085.30
#1 19.16
33,741.20
16.73
5,725
1.26
58.05
2,595.50
1,07,123.75
56.96
12,744.20
#1 20.90
2,007
-18.14
57.82
1,044.15
1,05,065.92
22.43
23,511.00
18.55
4,615
2.60
66.25
1,984.70
90,640.35
24.42
22,909.50
13.74
3,306
#1 51.64
54.20
31,100.00
66,085.33
45.79
6,684.70
9.64
1,414
11.55
34.59
5,410.00
64,684.67
27.98
13,458.30
3.70
2,216
21.39
60.00
Forecast
Actual
Growth Rate
Revenue Growth
10.50 %
Net Income Growth
19.23 %
Cash Flow Change
-1.85 %
ROE
-51.62 %
ROCE
-50.33 %
EBITDA Margin (Avg.)
-3.34 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
30
23
30
36
40
51
0
Expenses
30
22
27
28
31
41
0
EBITDA
0
0
3
8
9
10
0
Operating Profit %
1 %
1 %
10 %
22 %
22 %
20 %
0 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
3
7
8
10
0
Tax
0
0
1
2
2
2
0
Net Profit
0
0
2
5
6
7
0
EPS in ₹
1.77
0.88
42.54
6.72
5.36
6.26
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
11
10
13
21
38
48
Fixed Assets
2
2
2
2
4
6
Current Assets
8
8
10
19
30
33
Capital Work in Progress
0
0
1
0
0
0
Investments
0
0
0
0
0
13
Other Assets
9
9
11
20
34
0
Total Liabilities
11
10
13
21
38
48
Current Liabilities
4
3
4
6
2
5
Non Current Liabilities
0
0
0
1
1
1
Total Equity
7
7
9
15
36
43
Reserve & Surplus
7
7
8
7
24
31
Share Capital
1
1
1
8
12
12

Cash Flow

Cash Flow
2017
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
-0
0
5
Investing Activities
0
0
0
-1
0
-5
Operating Activities
0
-0
-0
1
0
-2
Financing Activities
0
0
1
0
0
11

Share Holding

% Holding
Aug 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Aug 2025
Promoter
56.89 %
56.89 %
56.89 %
54.97 %
52.32 %
52.32 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.22 %
30.18 %
30.23 %
40.12 %
43.24 %
42.69 %
Others
13.89 %
12.93 %
12.88 %
4.91 %
4.44 %
4.99 %
No of Share Holders
1,165
836
868
1,119
1,153
1,109

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 45.00 46.00
23 Sept 2025 DIVIDEND Dividend
₹ 0.35 /share
23 Sept 2025 45.00 46.00
23 Sept 2024 DIVIDEND Dividend
₹ 0.33 /share
23 Sept 2024 46.97 48.21
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 46.97 47.50
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 46.88 47.15
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 38.00 39.50
23 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
23 Jul 2025 39.60 43.97

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Notice Of 18Th Annual General Meeting4 days ago
Reg. 34 (1) Annual Report.4 days ago
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s9 days ago
Approved Tuesday 23Rd September 2025 As The Cut-Off Date As For The Purpose Of E-Voting And Dividend Entitlement. Dividend Shall Be Payable To Equity Shareholder; Whose Names Stand Registered On The CompanyS Register Of Members As Beneficial Owners As A9 days ago
To Close The Register Of Members Of The Company From Wednesday 24Th September 2025 To Tuesday 30Th September 2025 (Both Days Inclusive) For The Purpose Of Payment Of Dividend And Annual General Meeting.9 days ago
The 18Th Annual General Meeting Of The Company Will Be Held On Tuesday 30Th September 2025 At 10:00 A.M. At Registered Office Of The Company At Shelter Nagar Nr. S. T. Bus Stand Himmatnagar GJ 383001 IN Gujarat For The Financial Year Ended On 31St March 29 days ago
Corporate Action-Board approves Dividend9 days ago
Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday 02Nd September 20259 days ago
Board Meeting Intimation for Intimation Regarding Meeting Of The Board Of Directors Of The Company That Will Be Held On Tuesday 02Nd September 2025.Aug 27, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 20, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Selection Of Veterinary Products For Supply To AMULAug 08, 2025
Announcement under Regulation 30 (LODR)-AllotmentAug 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 06Th August 2025 For Allotment Of 8808000 WarrantsAug 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJul 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 12, 2025
Intimation Of Shelter PharmaS Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing RegulationsJul 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2025
Submission Of Notice Of 01/2025-26 Extra-Ordinary General Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 30, 2025
Convening Of 01/2025-26 Extra-Ordinary General Meeting (EGM) On Wednesday 23Rd July 2025 At 10:00 A.M At The Registered Office Of The Company. The Notice Of The Said EGM And Other Related Details Shall Be Submitted To The Stock Exchanges In Due Course In Jun 26, 2025
Fixed Thursday 17Th July 2025 As The Record Date For The Purpose Of Determining The Eligibility Of The Members To Attend And Vote (Including Through E-Voting) At The 01/2025-26 Extraordinary General Meeting (EGM) Of The Company Scheduled To Be Held On WedJun 26, 2025
Announcement under Regulation 30 (LODR)-Preferential IssueJun 26, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today On Thursday 26Th June 2025 And Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015Jun 26, 2025
Closure of Trading WindowJun 23, 2025
Board Meeting Intimation for Fund RaisingJun 23, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsJun 18, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today On Wednesday 18Th June 2025 And Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.Jun 18, 2025
Closure of Trading WindowJun 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).Jun 14, 2025
Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations 2015 For The Half Year And Year Ended March 2025.May 29, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 Regarding Appointment Of CA Ismail Ibrahimbhai Lakhani (M/S. I I LAKHANI & CO) FRN NO: 143750W Chartered Accountants As Internal AuditorMay 29, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 Regarding Reappointment Of M/S. Murtuza Mandorwala & Associates As Secretarial Auditor For The Period Of 5 YearsMay 29, 2025
Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31 2025May 29, 2025
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31 2025May 29, 2025
Board Meeting Intimation for Audited Financial Results For The Half Year Ended And Year Ended On March 31 2025May 24, 2025
Announcement Regulation 30 Read With Schedule III Part A Para B Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 14, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 21, 2025
Intimation With Regards To Shelter Pharma Limited Receives A+ Grading In FSSAI Audit Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015Feb 27, 2025
Appointment of Company Secretary and Compliance OfficerFeb 24, 2025
Board Meeting Outcome for Outcome Of Board Meeting - Appointment Of Company Secretary And Compliance Officer.Feb 24, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 17, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday January 28 2025Jan 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025

Technical Indicators

RSI(14)
Neutral
53.96
ATR(14)
Less Volatile
1.69
STOCH(9,6)
Neutral
38.28
STOCH RSI(14)
Neutral
30.18
MACD(12,26)
Bearish
-0.09
ADX(14)
Weak Trend
15.89
UO(9)
Bearish
49.69
ROC(12)
Downtrend And Accelerating
-0.02
WillR(14)
Neutral
-53.40